We recently showed that overexpression of REIC/ Dickkopf-3 (Dkk-3), a tumor suppressor gene, induced apoptosis in a tumor cell-specific manner. The aim of the present study was to determine the mechanisms underlying the selective induction of apoptosis. At first, we found a mouse renal carcinoma cell line, RENCA, to be extremely sensitive to an adenovirus carrying REIC/Dkk-3 (Ad-REIC), and we showed that activation of c-Jun N-terminal kinase (JNK) was a critical step in cell death, i.e. a process similar to that in human prostate and testicular cancer observed in our previous studies. Among the proteins interfering with the activation of JNK, heat shock protein (Hsp)70/72 was reduced in expression in RENCA cells compared with that in NIH3T3 cells. An Hsp70/72 inducer protected RENCA cells from Ad-REIC-induced apoptosis, while an Hsp70/72 inhibitor sensitized NIH3T3 cells for apoptosis induction. These results indicate that functionally active Hsp70/72 is a key factor in tumor cell-specific induction of apoptotic cell death and that analyses of the expression levels of Hsp70/72 may be essential in determining the significance of Ad-REICbased gene therapy against human cancer.
Introduction
The Dickkopf (Dkk) family is composed of 4 members, Dkk-1-4, that show distinct as well as similar biological functions (1) . Dkk-1 and -4 are known to interfere with Wnt signaling through the common receptor LRP5/6 (1-4). Since the Wnt signal pathway has been shown to be aggravated in many types of cancers (5-7), Dkk-1 is thought to behave as a tumor suppressor gene. Expression of endogenous Dkk-1 was shown to be reduced in human melanomas (8) , and forced expression of Dkk-1 resulted in increased apoptosis of various tumor cells (9) (10) (11) . Unlike Dkk-1 and -4, REIC/Dkk-3 does not bind to LPR5/6 or interfere with Wnt signaling (12, 13) . Nevertheless, expression of the REIC/Dkk-3 gene is suppressed in cells and tissues of many human cancers, including prostate cancer, renal clear cell carcinoma and nonsmall cell lung cancer (14) (15) (16) . More notably, expression of REIC/Dkk-3 using an adenovirus vector (Ad-REIC) selectively induced apoptosis in human prostate cancer cell lines (16) and a human testicular cancer cell line (17) with only a marginal effect on normal counterparts. Furthermore, human prostate cancer cells transplanted subcutaneously into nude mice were completely regressed in 4 out of 5 animals by a single injection of Ad-REIC (16) . The selective action of REIC/Dkk-3 is of profound significance and prompts further mechanistic study since the selective killing of malignant cells is the most critical issue for successful treatment of human cancer.
Our previous study showed that a membrane-permeable Bax inhibitor V5 completely abrogated the apoptosis induced in the prostate cancer cell line PC3 by infection with Ad-REIC (16) . Translocation of Bax protein from the cytoplasm to the mitochondria, a hallmark of the triggering of a Baxmediated apoptotic pathway, was completely suppressed by V5. The Ad-REIC infection activated c-Jun N-terminal kinase (JNK), one of the upstream activators of Bax in PC3 cells but not in normal human fibroblasts. The JNK-specific inhibitor SP600125 remarkably abrogated the Ad-REICinduced apoptosis of PC3 cells in a dose-dependent manner. These results indicate that overexpression of REIC/Dkk-3 activates JNK in a malignant cell-specific manner, induces mitochondrial translocation of Bax protein, and leads to apoptotic cell death. In the present study, we analyzed the mechanism of the cell type-specific activation of JNK by Ad-REIC after identification of a cell line highly sensitive to the Ad-REIC-induced apoptosis and thus suitable for the mechanistic study.
Heat shock proteins play a crucial role in tumor-specific apoptosis by REIC/Dkk-3 Immunoprecipitation and Western blot analysis. Total cell lysates were prepared at 36 h after adenovirus vector infection with a Triton X-100 lysis buffer (150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10 μg/ml leupeptin, 10 μg/ml aprotinin and 200 μg/ml phenylmethanesulfonyl fluoride, 10 mM Tris, pH 7.3). After saving aliquots of the samples for direct Western blot analysis, the cell lysates were cleared by treatment with excess amounts of TrueBlot™ anti-rabbit Ig IP beads (eBioscience, San Diego, CA) and incubated with rabbit anti-JNK/SAPK antibody (Cell Signaling) at 4˚C for 120 min. JNK and its associated proteins were recovered using TrueBlot anti-rabbit Ig IP beads. Western blot analysis was performed under conventional conditions. The antibodies used were as follows: rabbit anti-human REIC/Dkk-3 antibodies raised in our laboratory, a rabbit anti-human c-Jun antibody, a rabbit anti-human phospho-c-Jun (Ser63) antibody, a rabbit anti-human SAPK/JNK antibody, a rabbit antihuman phospho-SAPK/JNK (Thr183/Tyr185) antibody, a rabbit anti-human Hsp70/72 antibody (Cell Signaling Technology, Beverly, MA), a mouse monoclonal anti-human Hsp70/72 antibody (BD Biosciences), a mouse monoclonal anti-human Hsc70 antibody (Santa Cruz), and a mouse monoclonal anti-human ß-actin antibody (Sigma).
In vitro binding assay. Human Hsp70/72 cDNA was cloned and inserted into a pGEX6P3 vector (GE Health Care Biosciences). The Hsp70/72 protein was expressed as a GSTfused protein and purified using glutathione sepharose 4B (GE Health Care Biosciences). Fifty micromolars each of GST-Hsp70/72, JNK1α1 (active, Upstate), and JNK1α1 (inactive, Upstate) were incubated in PBS for 1 h at room temperature, recovered using glutathione sepharose 4B, and analyzed by Western blotting for JNK.
Results and discussion
Lack of REIC/Dkk-3 expression in RENCA cells. We first examined expression of the REIC/Dkk-3 gene in RENCA cells in comparison with that in NIH3T3 cells. Immunocytochemistry for REIC/Dkk-3 using two antibodies against full-length REIC/Dkk-3 protein, an antibody against an Nterminal region, and an antibody against a C-terminal region, consistently revealed a positive signal in the cytoplasm of NIH3T3 cells but never in RENCA cells (Fig. 1A) . The lack of expression of REIC/Dkk-3 in RENCA cells was confirmed by Western blot analysis (Fig. 1B) . This observation accords well with results of our previous studies showing that REIC/ Dkk-3 levels were reduced in tumor cells and tissues derived from various human organs, including the kidney (15) and prostate (16) .
Specific induction of apoptosis in RENCA cells by overexpression of REIC/Dkk-3.
Since our previous study showed that overexpression of REIC/Dkk-3 induced apoptosis in cancer cells but not in normal cells (16, 17) , we examined its effect on RENCA and NIH3T3 cells. We infected the cells with either Ad-LacZ or Ad-REIC at 20 MOI and monitored apoptotic cells by TUNEL staining 36 h after the infection. Similar expression levels of exogenous REIC/Dkk-3 protein were confirmed in NIH3T3 and RENCA cells (Fig. 4C ). As shown in Fig. 2 , however, 67% of Ad-REIC-infected RENCA cells were positive for TUNEL staining, while only 0.3% of Ad-REIC-infected NIH3T3 cells were positive. Ad-LacZ exerted a negligible effect on both RENCA and NIH3T3 cells. The highly sensitive and selective feature of REIC/Dkk-3-induced apoptosis in RENCA cells provides a suitable condition for a mechanistic study on tumor-specific induction of apoptosis by overexpression of REIC/Dkk-3 observed in a variety of malignant cells and tissues.
Involvement of JNK in Ad-REIC-induced apoptosis in RENCA cells. Our previous studies showed that JNK plays a major role in the induction of apoptosis by overexpression of REIC/ Dkk-3 in human cancer cells (16) . To determine whether this is also the case in RENCA cells, we examined the effect of a JNK inhibitor on Ad-REIC-induced cell death in RENCA cells (Fig. 3) . The JNK inhibitor SP600125 added to the cultures immediately after the virus infection dose-dependently abrogated the Ad-REIC-induced apoptotic cell death in RENCA cells, i.e. 30 and 100 nM of SP600125 reduced apoptotic cell rate in the untreated cells by 56 and 86%, respectively (Fig. 3B) , indicating a critical role of JNK in the apoptotic process. In accordance with this, JNK was shown to be activated in RENCA cells by infection with Ad-REIC but not by infection with Ad-LacZ as demonstrated by phosphorylation of JNK itself and its substrate c-Jun (Fig. 4C) . Neither JNK nor its substrate c-Jun was phosphorylated by Ad-REIC in NIH3T3 cells, where no induction of cell death was observed. A critical question to be addressed for understanding the mechanisms of the tumor-specific induction of apoptosis, therefore, is why and how JNK was activated in RENCA cells but not in NIH3T3 cells despite the fact that both types of cells were similarly infected with Ad-REIC. Activation of JNK was also shown to be a key event in Dkk-1-induced apoptosis by Lee et al (11) . Although Dkk-1 interferes with Wnt signaling, the activation of JNK by Dkk-1 did not involve the canonical Wnt signal pathway since they used a cell line lacking both alleles of ß-catenin. REIC/Dkk-3 is known not to interfere with Wnt signaling (12, 13) . We showed that the protein level and intracellular localization of ß-catenin remained unchanged in PC3 cells when the cells were infected with Ad-REIC and were undergoing apoptotic cell death (16) . An alternative and more likely possibility is that Ad-REIC-induced apoptosis may take place through activation of a stress-sensing mechanism for overload of specific proteins known as endoplasmic reticulum (ER) stress. It is well established that JNK is a key molecule leading cells in ER stress to apoptotic cell death, and inhibition of JNK abrogates the induction of apoptosis (18, 19) .
Heat shock proteins (Hsps) as a key factor for tumor-specific apoptosis by Ad-REIC.
A number of different proteins are known to bind to and inhibit the activity of JNK, including Hsp70/72, p21(WAF1), Rb, and GSTp (20) (21) (22) (23) . Among these, we focused on Hsp70/72 since the protein level of Hsp70/72 was reduced in RENCA cells compared with that in NIH3T3 cells (Fig. 4A) . Expression of a constitutively expressed Hsc70 was also reduced in RENCA cells, though to a lesser extent. Recombinant Hsp70/72 directly bound to JNK in vitro (Fig. 4B) . Binding of endogenous JNK and Hsp70/72 or Hsc70 was confirmed by immunoprecipitation followed by Western blot analysis (Fig. 4D ). Hsp90 and Hsp27 were expressed at lower levels in NIH3T3 cells than in RENCA cells, but neither protein interacted with JNK and hence were not considered to play significant roles in the present context (data not shown).
If the reduced Hsp70/72 level in RENCA cells is causatively linked to the sensitivity to Ad-REIC-induced apoptosis, induction of Hsp70/72 should suppress the apoptotic death of the cells. When RENCA cells were treated with the Hsp70/72 inducer geranylgeranylacetone at 10 μM, Hsp70/72 was induced to a level slightly less than that of untreated NIH3T3 cells (Fig. 4C) . The induction of Hsp70/72 resulted in abrogation of activation of JNK (Fig. 4C ) and of apoptotic cell death (Fig. 5) by Ad-REIC infection. The apoptotic cell rate determined 36 h after the Ad-REIC infection was reduced from 66.5% in untreated RENCA cells to 15.1 and 7.9% in the cells treated with 5 and 10 μM of geranylgeranylacetate, respectively (Fig. 5B) .
On the other hand, exposure of cells to an Hsp70/72 inhibitor sensitized NIH3T3 cells to apoptosis induction by Ad-REIC in a dose-dependent manner from 10-50 μM (Fig. 6) . The ratios of apoptotic cells were only 1.6% in NIH3T3 cells simply infected with Ad-REIC and 39.1% in the cells treated with 50 μM of an Hsp70/72 inhibitor in addition to the virus infection (Fig. 6) . JNK was activated as assessed by detecting phosphorylated c-Jun in Ad-REICinfected NIH3T3 cells treated with 50 μM of the inhibitor but not in the untreated cells (Fig. 4C) . Treatment with the Hsp70/72 inhibitor dose-dependently induced apoptosis even in non-infected and Ad-LacZ-infected RENCA cells and reinforced apoptotic cell death in Ad-REIC-infected cells (Fig. 6) . These results indicate that the tumor cell-specific apoptosis induced by overexpression of REIC/Dkk-3 was mainly due to the functional difference of Hsp70/72. Hsp70/72 has been shown to inhibit apoptosis induced by a broad variety of agents, including stresses (24) (25) (26) (27) (28) . Although Park et al (20) demonstrated that Hsp72(70) inhibited heat-induced activation of JNK through direct interaction in NIH3T3 cells, many lines of evidence indicate that the mechanism of anti-apoptotic action of Hsp70/72 is pleiotropic depending on cell type and apoptotic stimuli. Hsp70/72 prevented stress-induced apoptosis of a human T-lymphocyte cell line by acting not only on JNK but also at some point downstream of JNK (27) . Buzzard et al (28) showed that constitutively expressed Hsp70/72 inhibited apoptosis of mouse embryonic fibroblasts by heat, ceramide, or TNFα but did not affect JNK activity. Hsp70/72 exerted its anti-apoptotic action not at the stage of JNK but at a downstream step of caspase 3-like proteases (29) .
In the present study, we obtained evidence that the functional state of Hsp70/72 correlates well with resistance to apoptosis induced by overexpression of REIC/Dkk-3. Our preliminary screening revealed that human cancer cells largely differ in sensitivity to Ad-REIC-induced apoptosis and that the sensitivity depends on expression levels of anti-apoptotic proteins, including Hsp70/72. The results of the present study may contribute to the establishment of a convenient and reliable method to distinguish the sensitivity of different human tumors to gene therapy using Ad-REIC.
In conclusion, through the present study we analyzed the mechanism of tumor cell-specific induction of apoptosis by Ad-REIC using a cell line highly sensitive to apoptosis induction. Among the proteins interfering with the activation of JNK, a critical event for Ad-REIC-induced apoptosis was the reduced expression of Hsp 70/72 in RENCA cells compared with that in NIH3T3 cells. An Hsp70/72 inducer protected RENCA cells from Ad-REIC-induced apoptosis, while an Hsp70/72 inhibitor sensitized NIH3T3 cells for apoptosis induction. These results indicate that functionally active Hsp70/72 is a determining factor for tumor cellspecific induction of apoptotic cell death and that analyses of the expression levels of Hsp70/72 may contribute to the identification of human cancers sensitive to gene therapy using Ad-REIC.
